In this prospective longitudinal cohort study, conducted from 2018 to 2023, we evaluated 4090 individuals, aged 45 to 75, without a prior diagnosis of atrial fibrillation (AF) to assess the predictive value of NT-proBNP levels for the development of AF. This evidence concerns the gene NPPB and atrial fibrillation.